A third of patients travel more than 150 miles for care at the Salt Lake City cancer center. But for patients even further ...

Understanding the differences in the mutations that ... Mar. 13, 2025 — Researchers have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with ...

The polyps have a high likelihood of becoming colon cancer by the time these patients reach their mid to late 40s, but the screening rate is the lowest among people in this age group. Why? People ...

Correspondence to Dr Eileen Morgan, International Agency for Research on Cancer, 69372 Lyon CEDEX 08 ... Results Over 1.9 million new CRC cases and 930 000 deaths were estimated in 2020. Incidence ...

Innovative Dual-Target Drug May Lead to New Investigational Approach for Breast Cancer Patients Feb. 12, 2025 — Researchers discover new insights into how dual-target drug may supercharge cancer ...

The new Sassun-Mayo staging system, which integrates tumor deposit and lymph node counts, improves prognostic accuracy for patients with colon cancer compared with the standard American Joint ...

Chris Boshoff, Pfizer’s chief oncology officer Its new chief oncology officer, Dr Chris Boshoff, said the focus will be on four main cancer types: breast cancer, genitourinary cancers including ...

Rural cancer patients may miss out on cutting-edge ... Nevada and Wyoming — because it’s also the regional hub for NIH-funded studies of new treatments. So Ulrich’s center helps train ...

KCCI EIGHT NEWS AT SIX. NEW. TODAY, OUR STATE CONTINUES TO BE ONE OF THE TOP IN THE NATION IN NEW CASES OF CANCER. IOWA IS NUMBER TWO FOR THE THIRD YEAR IN A ROW. THAT’S ACCORDING TO THE LATEST ...

NEW. TODAY, OUR STATE CONTINUES TO BE ONE OF THE TOP IN THE NATION IN NEW CASES OF CANCER. IOWA IS NUMBER TWO FOR THE THIRD YEAR IN A ROW. THAT’S ACCORDING TO THE LATEST CANCER IN IOWA REPORT ...

Here are the latest new cancer drugs approved by the Food and Drug Administration: Aucatxyl (obecabtagene autoleucel), a new CAR-T therapy for acute lymphoblastic leukemia Bizengri (zenocutuzumab), a ...